Letko, Brosseau & Associates’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Letko, Brosseau & Associates’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-87,300	Closed	-$8.34M	–	106
2015 Q1	$8.34M	Sell	87,300 -9,600	-10%	-$718K	0.08%	76
2014 Q4	$6.51M	Hold	96,900	–	–	0.06%	80
2014 Q3	$5.23M	Hold	96,900	–	–	0.04%	82
2014 Q2	$4.31M	Hold	96,900	–	–	0.03%	82
2014 Q1	$3.37M	Hold	96,900	–	–	0.03%	81
2013 Q4	$2.8M	Buy	96,900 +64,000	+195%	+$1.86M	0.02%	85
2013 Q3	$961K	Buy	+32,900	New	+$820K	0.01%	88

Other funds holding CBPO

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Letko, Brosseau & Associates's CBPO Position: Q2 2015 in Review

Letko, Brosseau & Associates sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2015, closing a stake of 87,300 shares — an estimated $8.34M sold.

Letko, Brosseau & Associates first reported a position in CBPO in Q3 2013 and held it in 7 quarters. The position peaked at $8.34M in Q1 2015. 109 funds tracked by Wall St. Rank hold CBPO as of Q2 2015.

Letko, Brosseau & Associates reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2015 after selling out during the quarter.
Letko, Brosseau & Associates sold 87,300 China Biologic Products Holdings, Inc. shares in Q2 2015, an estimated $8.34M.
Letko, Brosseau & Associates first reported a position in China Biologic Products Holdings, Inc. in Q3 2013 and held it in 7 quarters.
Letko, Brosseau & Associates's China Biologic Products Holdings, Inc. position peaked at $8.34M in Q1 2015.
109 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2015.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2015, filed 4 Aug 2015.